As part of PharmTech’s coverage of CPHI Milan, Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, ...
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains that developing a molecule requires a ...
High-concentration biologics are pushing the limits of what can be formulated, filled, and delivered as a low-volume ...
Sanofi and Cheplapharm have announced plans for a strategic partnership that would transfer 20 mature medicines and three ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results